These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Acute closure-angle glaucoma after treatment with ipratropium bromide and salbutamol aerosols]. De Saint Jean M; Bourcier T; Borderie V; Moldovan M; Touzeau O; Laroche L J Fr Ophtalmol; 2000 Jun; 23(6):603-5. PubMed ID: 10880928 [TBL] [Abstract][Full Text] [Related]
3. Bilateral acute angle closure developing due to use of ipratropium bromide and salbutamol. Kola M; Hacıoğlu D; Erdöl H; Türk A Int Ophthalmol; 2018 Feb; 38(1):385-388. PubMed ID: 28168569 [TBL] [Abstract][Full Text] [Related]
4. [Acute glaucoma in the course of treatment with aerosols of ipratropium bromide and salbutamol]. Lellouche N; Guglielminotti J; de Saint-Jean M; Alzieu M; Maury E; Offenstadt G Presse Med; 1999 May 22-29; 28(19):1017. PubMed ID: 10379349 [No Abstract] [Full Text] [Related]
5. Acute angle closure glaucoma associated with nebulised ipratropium bromide and salbutamol. Shah P; Dhurjon L; Metcalfe T; Gibson JM BMJ; 1992 Jan; 304(6818):40-1. PubMed ID: 1531182 [No Abstract] [Full Text] [Related]
7. Acute angle closure glaucoma occurring after nebulized bronchodilator treatment with ipratropium bromide and salbutamol. Reuser T; Flanagan DW; Borland C; Bannerjee DK J R Soc Med; 1992 Aug; 85(8):499-500. PubMed ID: 1404209 [No Abstract] [Full Text] [Related]
8. Acute angle-closure glaucoma as a complication of combined beta-agonist and ipratropium bromide therapy in the emergency department. Hall SK Ann Emerg Med; 1994 Apr; 23(4):884-7. PubMed ID: 8161065 [TBL] [Abstract][Full Text] [Related]
9. Ocular hazards of nebulized bronchodilators. Mulpeter KM; Walsh JB; O'Connor M; O'Connell F; Burke C Postgrad Med J; 1992 Feb; 68(796):132-3. PubMed ID: 1533281 [TBL] [Abstract][Full Text] [Related]
10. [Asynchronous double-sided angle-closure glaucoma--a condition in an ipratropium/terbutaline treated patient under artificial ventilation]. Rasmussen H; Berger A Ugeskr Laeger; 1994 Nov; 156(48):7235-6. PubMed ID: 7817438 [TBL] [Abstract][Full Text] [Related]
11. [Acute angle-closure glaucoma and ipratropium bromide]. Ortiz Rambla J; Hidalgo Mora JJ; Gascón Ramón G; Navarro Arambudo B Med Clin (Barc); 2005 May; 124(20):795. PubMed ID: 15927109 [No Abstract] [Full Text] [Related]
13. Inhaled albuterol/salbutamol and ipratropium bromide and their combination in the treatment of chronic obstructive pulmonary disease. Gordon J; Panos RJ Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):381-92. PubMed ID: 20163324 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological mydriasis secondary to ipratropium bromide: a cause of unilateral dilated pupil. Sharma NS; Ooi JL; Papalkar D; Sharma S; Francis IC; Fung VS J Clin Neurosci; 2008 Mar; 15(3):320-1. PubMed ID: 18191575 [TBL] [Abstract][Full Text] [Related]
15. Bronchodilation and safety of supratherapeutic doses of salbutamol or ipratropium bromide added to single dose GSK961081 in patients with moderate to severe COPD. Norris V; Ambery C Pulm Pharmacol Ther; 2013 Oct; 26(5):574-80. PubMed ID: 23524017 [TBL] [Abstract][Full Text] [Related]
17. A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD. Donohue JF; Kalberg C; Emmett A; Merchant K; Knobil K Treat Respir Med; 2004; 3(3):173-81. PubMed ID: 15219176 [TBL] [Abstract][Full Text] [Related]
18. Does high dose ipratropium bromide added to salbutamol improve pulmonary function for patients with chronic obstructive airways disease in the emergency department? Koutsogiannis Z; Kelly AM Aust N Z J Med; 2000 Feb; 30(1):38-40. PubMed ID: 10800876 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD. Bhattacharya A; Bhargava S; Singh V; Talwar D; Whig J; Rebello J; Purandare S; Gogtay J Int J Chron Obstruct Pulmon Dis; 2016; 11():1469-76. PubMed ID: 27418820 [TBL] [Abstract][Full Text] [Related]